Life Sciences & Biotechnology
Research Agricultural
Total number of Record(s): 5828
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Research in ASTHI: Pre-clinical development of CDRI optimized lead molecules as dual osteogenic and muscle anabolic agents | Dr Naibedya Chattopadhyay, Scientist, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Osteoporosis |
| Structural and functional characterization of potential drug target proteins from ESKAPE pathogens | Dr Ashish Arora, Scientist, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Characterization of potential drug target |
| Unravelling cognitive impairments due to ageing and neurodegeneration | Dr PN Yadav, Scientist, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Ageing and neurodegeneration |
| SREBP inhibitors as novel therapeutics for non-alcoholic fatty liver disease: Insights on CRISPER-Cas9 inhibition of SREBPs targeting activated hepatic stellate cells | Dr P. Madan Kumar, Scientist, CSIR-Central Food Technological Research Institute (CFTRI), Karnataka | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Non-alcoholic fatty liver disease |
| Anti-virulent therapy and nutraceutical formulation from edible microalgae Chlorella varaibilis (ATCC PTA 12198) against toxigenic Vibrio cholerae | Dr Saumya Ray Chaudhari, Scientist, CSIR-Central Salt & Marine Chemicals Research Institute (CSIR-CSMCRI), Bhavnagar | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Therapy for cholera |
| Identifying modifiers of genetic diseases for preventive and prognostic interventions: focus on hematological and neurological diseases (GATII, Genomics Assisted target Identification and Intervention | Sivaprakash Ramalingam, Scientist, CSIR-Institute of Genomics & Integrative Biology (CSIR-IGIB), New Delhi | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Genetic Diseases |
| In vivo RNAi mediated intervention in neuro-inflammation pathway for development of therapeutic strategy | Beena Pillai, Scientist, CSIR-Institute of Genomics & Integrative Biology (CSIR-IGIB), New Delhi | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Neuro-inflammation pathway |
| Intercepting host immunometabolism with granuloma adapted tubercle bacilli | Dr Vivek Rao, Scientist, CSIR-Institute of Genomics & Integrative Biology (CSIR-IGIB), New Delhi | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Granuloma |
| Molecular mechanisms of how non-coding RNAs impact epigenetic regulation | Beena Pillai Scientist, CSIR-Institute of Genomics & Integrative Biology (CSIR-IGIB), New Delhi | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Epigenetic regulation |
| Transgenerational effect of paternal and maternal vitamin B12 deficiency | Dr Shantanu Sengupta, Scientist, CSIR-Institute of Genomics & Integrative Biology (CSIR-IGIB), New Delhi | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Study of vitamin deficiency in animal model |